Nov 20, 2025 • Zacks Commentary
BULLISH
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Nov 10, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Wall Street Analysts Believe Omnicell ( OMCL ) Could Rally 34.53%: Here's is How to Trade
The consensus price target hints at a 34.5% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Nov 04, 2025 • Zacks Commentary
BULLISH
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell ( OMCL Quick QuoteOMCL - ) and Hims & Hers Health, Inc. ( HIMS Quick QuoteHIMS - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer ...
Nov 04, 2025 • Benzinga
BULLISH
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal - Evoke Pharma ( NASDAQ:EVOK )
Evoke Pharma, Inc. ( NASDAQ:EVOK ) shares are surging on Tuesday after the company announced it has entered into a deal to be acquired by QOL Medical for $11 per share in cash via a tender offer. The purchase price offers a 139.7% premium to Evoke's November 3, 2025, closing share price.
Nov 04, 2025 • Zacks Commentary
BULLISH
Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025
Five robotics-driven stocks - PATH, EMR, TRMB, OMCL and LECO - are set to gain traction heading into late 2025.
Nov 03, 2025 • Zacks Commentary
BULLISH
Earnings Estimates Moving Higher for Omnicell ( OMCL ) : Time to Buy?
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.